Figure 1.
(a) The possible structure of the ruthenium-fluvastatin complex. (b–d) Receptor-ligand hydrogen bonding interactions of Ru-flu with active site residues of gamma-synuclein.
(a) The possible structure of the ruthenium-fluvastatin complex. (b–d) Receptor-ligand hydrogen bonding interactions of Ru-flu with active site residues of gamma-synuclein.